Music-STAR trial: study protocol for a randomised controlled trial to assess the impact of live and recorded music-based interventions on preoperative stress, mood, pain and biomarkers in neurosurgical patients
4 affiliations
- 1Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 2Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 3Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 4Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Abstract
Introduction: Neurosurgical patients commonly experience significant preoperative anxiety, which can negatively impact surgical outcomes and recovery trajectories. Music, as a powerful neurophysiological modulator of the human stress response, offers a non-pharmacological, non-invasive and cost-effective approach to anxiolysis by stabilising the hypothalamic-pituitary-adrenal axis and autonomic nervous system. The goal of this study is to evaluate the effects of live and recorded music on preoperative stress, serum-level and plasma-level biomarkers, perceived pain, anxiety and mood states in neurosurgical cancer patients.
Methods and analysis: Enrolled neurosurgical patients (n=132) will be equally randomised to one of three groups: (1) simulated live music intervention using a Steinway Spirio M recording/player piano, (2) recorded music played through ambient speakers, or (3) control (no music). The musical selections will all incorporate 16 validated Compositional Elements of Relaxation (CERs). The intervention period will last 30 min.
Endpoints will be assessed using validated pre-intervention and post-intervention questionnaires, including the State-Trait Anxiety Inventory–State subscale (STAI-S), the Profile of Mood States–Short Form (POMS-SF), and the Visual Analogue Scale for Pain (VASP), as well as serum biomarkers (eg, interleukin-6, cortisol and epinephrine) analysed using broad-spectrum proteomic and metabolomic approaches.
The study will be conducted from January 2025 to January 2028.
Ethics and dissemination: This study protocol was approved by the review board at MD Anderson Cancer Center on 12 May 2025. The results of this study will be disseminated through peer-reviewed journals and presented at relevant scientific conferences.
Trial registration number: NCT06536504 .
Related
- Comparative effectiveness of exercise and self-management interventions delivered through different modes of digital support on pain and patient-reported physical function in people with knee osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials
- Educational and behavioural interventions for reducing fear of hypoglycaemia in adults with type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials
- Reporting of justifications for withholding established effective interventions in randomised placebo-controlled trials: a systematic review.
- Effectiveness of interventions to promote couples-based HIV testing and family health during pregnancy and postpartum in Kenya: a multicentre, couples-based, randomised controlled trial
- Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials
BibTeX
@article{anyanwu2026musicstar,
title = {{Music-STAR trial: study protocol for a randomised controlled trial to assess the impact of live and recorded music-based interventions on preoperative stress, mood, pain and biomarkers in neurosurgical patients}},
author = {Amara Anyanwu and Dima Suki and Annelise Huynh and Giulio Draetta and Kyle Noll and J Jack Lee and Frederick F Lang and Mei Rui},
journal = {BMJ Open},
year = {2026},
month = oct,
doi = {10.1136/bmjopen-2025-110925},
url = {https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2025-110925},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Music-STAR trial: study protocol for a randomised controlled trial to assess the impact of live and recorded music-based interventions on preoperative stress, mood, pain and biomarkers in neurosurgical patients
AU - Amara Anyanwu
AU - Dima Suki
AU - Annelise Huynh
AU - Giulio Draetta
AU - Kyle Noll
AU - J Jack Lee
AU - Frederick F Lang
AU - Mei Rui
PY - 2026
DA - 2026/10/05
JO - BMJ Open
DO - 10.1136/bmjopen-2025-110925
UR - https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2025-110925
AB - Introduction: Neurosurgical patients commonly experience significant preoperative anxiety, which can negatively impact surgical outcomes and recovery trajectories. Music, as a powerful neurophysiological modulator of the human stress response, offers a non-pharmacological, non-invasive and cost-effective approach to anxiolysis by stabilising the hypothalamic-pituitary-adrenal axis and autonomic nervous system. The goal of this study is to evaluate the effects of live and recorded music on preoperative stress, serum-level and plasma-level biomarkers, perceived pain, anxiety and mood states in neurosurgical cancer patients. Methods and analysis: Enrolled neurosurgical patients (n=132) will be equally randomised to one of three groups: (1) simulated live music intervention using a Steinway Spirio M recording/player piano, (2) recorded music played through ambient speakers, or (3) control (no music). The musical selections will all incorporate 16 validated Compositional Elements of Relaxation (CERs). The intervention period will last 30 min. Endpoints will be assessed using validated pre-intervention and post-intervention questionnaires, including the State-Trait Anxiety Inventory–State subscale (STAI-S), the Profile of Mood States–Short Form (POMS-SF), and the Visual Analogue Scale for Pain (VASP), as well as serum biomarkers (eg, interleukin-6, cortisol and epinephrine) analysed using broad-spectrum proteomic and metabolomic approaches. The study will be conducted from January 2025 to January 2028. Ethics and dissemination: This study protocol was approved by the review board at MD Anderson Cancer Center on 12 May 2025. The results of this study will be disseminated through peer-reviewed journals and presented at relevant scientific conferences. Trial registration number: NCT06536504 .
SN - 2044-6055
SN - 2044-6055
ER -